Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 946-037-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
- Skin irritation/corrosion: irritating, based on the rules of the CLP Regulation for classification of mixtures
- Eye irritation: not irritating (OECD TG 492, GLP, Rel.1)
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 19 - 26 November 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- GLP study conducted in compliance with OECD Guideline No. 492 without any deviation.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- 05 March 2015
- Species:
- human
- Details on test animals or tissues and environmental conditions:
- Species: Reconstructed human Cornea-like Epithelium (tissues).
Supplier: MatTek, Bratislava, Slovak Republic.
Selection: at receipt, the tissues were inspected for obvious defects as they could have been rejected based on blistering, excess fluid or air bubbles below the tissue insert. Cultures with air bubbles under the insert covering greater than 50% of the insert area were not used.
Storage conditions: at receipt, the living EpiOcular™ tissues were stored as described in the Pre-incubation of the tissues on their day of arrival. - Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 50 μL
- Concentration (if solution): Undiiluted - Duration of treatment / exposure:
- Test item, negative and positive controls were applied topically on duplicate tissues and incubated at 37 °C, 5% CO2 in a humidified incubator for 30 minutes (± 2 minutes).
- Duration of post- treatment incubation (in vitro):
- At the end of the treatment period, each tissue was rinsed with D-PBS, incubated for 12 minutes (± 2 minutes) at room temperature to remove any remaining test item absorbed into the tissue, blotted on absorbent material, and then incubated for another 120 minutes (± 15 minutes) at 37 °C, 5% CO2 in a humidified incubator.
- Number of animals or in vitro replicates:
- Test item, negative and positive controls were applied on duplicate tissues.
- Details on study design:
- RhCE tissue construct used: The EpiOcular™ model consists of an airlifted, living, multilayered ocular tissue construction (surface 0.60 cm2), reconstructed from normal (non-transformed) human-derived keratinocytes. This is a non-keratinized epithelium which models the cornea epithelium with progressively stratified, but not cornified cells. The cells are cultured in proprietary serum-free culture media, which induces corneal differentiation and the formation of the organotypic 3D cornea-like model. The 3D tissue consists of highly organized cell layers similar to that found in the cornea. The model features a normal ultra-structure and is functionally equivalent to human in vivo tissue. The EpiOcular tissues were used within 72 h of their production.
Preliminary tests: Preliminary tests were performed to detect the ability of the test item to directly reduce MTT as well as its coloring potential.
- Test for direct MTT reduction with the test item: 50 μL of the test item or negative control were added to 1 mL of a 1.0 mg/mL MTT solution, then incubated in darkness at 37 °C for 3 h (± 10 minutes) and color of the solutions obtained was evaluated.
- Test for the detection of the coloring potential of the test item: The maximum amount of test item, 50 μL was added to 1 mL of water and incubated for at least 1 hour in the dark at 37 °C, 5% CO2 and 2 mL of isopropanol, incubated in a 6-well plate and placed on an orbital plate shaker for 2 to 3 h at room temperature. After that, the presence and intensity of the coloration were evaluated.
Main test:
- Doses of test chemical and control substances used: 50 μL
- Pre-incubation of the tissues: Tissues were equilibrated to room temperature for at least 15 minutes. The tissue inserts were transferred aseptically into the 6-well plate and pre-incubated at 37 °C, 5% CO2 in a humidified incubator for 1 h. After the pre-incubation period, the assay medium was removed and replaced by 1 mL of fresh assay medium before incubation overnight (16-24 h) at 37 °C, 5% CO2 in a humidified incubator.
Treatment of tissues
- Duration and temperature of exposure, post-exposure immersion and post-exposure incubation periods: Test item and both negative and positive controls were applied topically on duplicate tissues and incubated at 37 °C, 5% CO2 for 30 minutes (± 2 minutes). At the end of the treatment period, each tissue was rinsed with D-PBS, incubated for 12 minutes (± 2 minutes) at room temperature to remove any remaining test item absorbed into the tissue, blotted on absorbent material, and then incubated for another 120 minutes (± 15 minutes) at 37 °C, 5% CO2 in a humidified incubator.
- Number of tissue replicates used per test chemical and controls (positive control, negative control): One 6-well plate was used for the first test item-treated tissues. Positive and negative controls were placed on separate 6-well plates (one plate for each).Test item, negative and positive controls were applied on duplicate tissues.
- MTT viability assay: Following the post-treatment incubation, the cell viability was assessed by means of the colorimetric MTT reduction assay. Tissues were incubated with MTT solution in 24-well plates for 3 h (± 10 minutes) at 37 °C, 5% CO2 in a humidified incubator. At the end of the 3 h incubation period, tissues were blotted on absorbent paper and the degree of MTT staining was evaluated. For the test item, negative and positive control-treated tissues, the inserts were transferred to new wells of the 24-well plate containing 2 mL of isopropanol per well. Formazan extraction was performed overnight at 2-8 °C and protected from light.
- Optical Density measurements: At the end of the formazan extraction period, tissues (test item, negative and positive control-treated tissues) were pierced. The extract solution was mixed and two 200 μL aliquots were transferred to the pre-labeled 96-well plate. For each 96-well plate, the average Optical Density value (OD) of 4 wells containing 200 μL of isopropanol only was used as the blank. The OD was measured at 570 nm using a plate reader.
Mean viability values were calculated for each tissue and expressed as a percentage of the mean viability of the negative control tissues which was set at 100% (reference viability). - Irritation parameter:
- other: relative mean viability of the tissues (%)
- Run / experiment:
- 30 minutes
- Value:
- 98
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- PRELIMINARY TESTS
Test for direct MTT reduction with the test item: The MTT solution containing the test item did not turn blue/purple when compared with the negative control. The test item was therefore considered not to have direct MTT reducing properties. As a result, no additional controls were performed on freeze-dead tissues in parallel to the main test.
Test for the detection of the colouring potential of the test item: During this test, as both water and isopropanol solutions containing the test item did not change colour, the test item was found not to have a colouring potential. As a result, no additional controls were used in parallel to the main test.
MAIN TEST
Evaluation of the colouration of tissues at the end of the MTT incubation period: Test item-treated tissues appeared to be blue which was considered indicative for viable tissues. Negative control tissues appeared to be blue and positive control tissues were white/blue (with blue colouration at the periphery of tissues only) which was considered to be indicative of viable and semi-viable tissues, respectively.
Evaluation of the MTT results: The relative mean viability of the tissues treated with the test item was 98% with a standard deviation of 3%. As the mean viability was > 60% after the MTT reduction, the results met the criteria for a non-irritant response.
ACCEPTANCE OF RESULTS:
- All of the acceptance criteria for the negative and positive controls were fulfilled, therefore the study was considered to be valid. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the experimental conditions of this study, the test item, OLIBANUM ESSENTIAL OIL, is considered to be non-irritant to Reconstructed human Cornea-like Epithelium. According to the results of this study, the classification of the test item should be: no category (GHS 2013 and Regulation (EC) No. 1272/2008).
- Executive summary:
An in vitro eye irritation test on the EpiOcularTM cornea epithelial model was performed according to the OECD Guideline 492 and in compliance with GLP to predict the acute eye irritation potential of the test item.
Preliminary tests were performed to detect the ability of the test item to directly reduce MTT as well as its colouring potential. Following the preliminary tests, the eye irritation potential of the test item was assessed in the main test. The test item and both the negative and positive controls were applied topically on duplicate tissues and incubated at 37 °C for 30 minutes. At the end of the treatment period, each tissue was rinsed with D-PBS, incubated for 12 minutes at room temperature to remove any remaining test item absorbed into the tissue, blotted on absorbent material, and then incubated for another 120 minutes at 37 °C, 5% CO2 in a humidified incubator. The cell viability was then assessed by means of the colourimetric MTT reduction assay. Mean viability values were calculated for each tissue and expressed as a percentage of the mean viability of the negative control tissues which was set at 100% (reference viability).
In the preliminary tests, the test item was found not to have direct MTT reducing properties or colouring potential.
All acceptance criteria for the negative and positive controls were fulfilled. The study was therefore considered to be valid.
The relative mean viability of the tissues treated with the test item was 98% with a standard deviation of 3%. As the mean viability was > 60% after the MTT reduction, the results met the criteria for a non-irritant response.
Under the experimental conditions of this study, the test item, OLIBANUM ESSENTIAL OIL, is considered to be non-irritant to Reconstructed human Cornea-like Epithelium. According to the results of this study, the classification of the test item should be: no category (GHS 2013 and Regulation (EC) No. 1272/2008).
Reference
Table 7.3.2/1: Main test: Individual and mean corrected OD values and tissue viabilities for the test item, the negative and positive controls
Group |
Exposure duration |
Tissue No. |
OD570 nm measurements |
|
Mean blank |
cOD570 nm measurements |
|
Mean cOD570 nm |
Viability (%) |
1st |
2nd |
1st |
2nd |
||||||
Negative control |
30 min |
1 |
1.950 |
1.889 |
0.037 |
1.913 |
1.852 |
1.883 |
106 |
2 |
1.719 |
1.699 |
1.682 |
1.662 |
1.672 |
94 |
|||
Positive control |
30 min |
1 |
0.893 |
0.873 |
0.037 |
0.856 |
0.836 |
0.846 |
48 |
2 |
0.960 |
0.915 |
0.923 |
0.878 |
0.901 |
51 |
|||
Test item |
30 min |
1 |
1.851 |
1.778 |
0.037 |
1.814 |
1.741 |
1.777 |
100 |
2 |
1.740 |
1.721 |
1.703 |
1.684 |
1.693 |
95 |
Table 7.3.2/2: Main test - Mean tissue viability and standard deviations for the test item, the negative and positive controls
Group |
Exposure duration |
cOD570 nm |
Viability (%) |
|||
Mean |
SD |
Mean |
SD |
Difference (%) |
||
Negative control |
30 min |
1.777 |
0.149 |
100 |
8 |
12 |
Positive control |
30 min |
0.873 |
0.039 |
49 |
2 |
3 |
Test item |
30 min |
1.735 |
0.059 |
98 |
3 |
5 |
OD = optical density
cOD = blank corrected optical density
SD = standard deviation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Skin irritation/corrosion:
The decision logic for classification of mixtures from the ECHA Guidance on the Application of the CLP Criteria (2015) was used to determine the skin irritation/corrosion hazard of the registered substance. The decision of classification as skin irritant was based on existing data on constituents (additivity principles): the registered substance has more than 10% of its constituents classified as Skin irritant Category 2 and should be classified as a skin irritant without further testing according to the rules for classification of mixtures of Regulation (EC) No 1272/2008
Constituent |
Classification according to the Regulation (EC) No. 1272/2008 (CLP) |
Source |
|
Skin irritation |
Eye irritation |
||
d-limonene |
SCI 2 (H315) |
- |
Harmonised classification |
l-limonene |
SCI 2 (H315) |
- |
Self-classification |
alpha-pinene | SCI 2 (H315) |
- | Self-classification |
myrcene |
SCI 2 (H315) |
- |
Self-classification |
p-cymene |
SCI 2 (H315) |
- |
Self-classification |
Source: ECHA disseminated dossiers or self-classification
Eye irritation:
A key study was identified on the registered substance. This in vitro eye irritation test on the EpiOcularTM cornea epithelial model was performed according to the OECD Guideline 492 and in compliance with GLP.
All acceptance criteria for the negative and positive controls were fulfilled. The study was therefore considered to be valid.
The relative mean viability of the tissues treated with the test item was 98% with a standard deviation of 3%. As the mean viability was > 60% after the MTT reduction, the results met the criteria for a non-irritant response.
Based on the results, the registered substance is considered to be non-irritant to Reconstructed human Cornea-like Epithelium.
Justification for classification or non-classification
Harmonized classification:
The registered substance has no harmonized classification according to the Regulation (EC) No. 1272/2008.
Self-classification:
Based on the available information and typical composition provided by the Lead Registrant, the registered substance is classified as skin irritant: Skin Irritant Category 2 (H315: Causes skin irritation) according to the criteria of the Regulation (EC) No. 1272/2008 (CLP).
Based on the available data on the registered substance, it is not classified for eye irritation according to the criteria of the Regulation (EC) No. 1272/2008 (CLP) .
No information was available regarding respiratory irritation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.